|
⚲
|
| Keyboard |
| Kleanthis Xanthopoulos | |
|---|---|
| Firm | |
| Address | c/o Shoreline Biosciences, Inc 11408 Sorrento Valley Road San Diego, CA 92121 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Shoreline Biosciences Inc | 021-420540 | Executive Officer | 140.0 M of 140.0 M |
||
| Sente Inc | 021-315571 | Director | 8.5 M of 18.5 M |
||
| Apricus Biosciences Inc | 021-295477 | Director | 3.7 M of 3.7 M |
||
| Sente Inc | 021-288265 | Director | 5.0 M of 5.0 M |
||
| Apricus Biosciences Inc | 021-272379 | Director | 3.7 M of 3.7 M |
||
| Zosano Pharma Corp | 021-269677 | Director | 7.5 M of 7.5 M |
||
| Bioniz Therapeutics Inc | 021-254158 | Director | 15.6 M of 18.6 M |
||
| Zosano Pharma Corp | 021-242801 | Director | of 0.3 M |
||
| Zosano Pharma Corp | 021-233401 | Director | 15.0 M of 15.0 M |
||
| Zosano Pharma Corp | 021-229480 | Director | 1.3 M of 2.0 M |
||
| Sente Inc | 021-218893 | Director | 5.0 M of 5.0 M |
||
| ZP Holdings Inc | 021-212939 | Director | 2.5 M of 2.5 M |
||
| Regulus Therapeutics Inc | 021-211442 | Executive Officer | 10.0 M of 10.0 M |
||
| Zosano Inc | 021-206338 | Director | 0.4 M of 0.4 M |
||
| ZP Holdings Inc | 021-203196 | Director | 3.0 M of 3.0 M |
||
| Sente Inc | 021-193732 | Executive Officer | 2.1 M of 2.2 M |
||
| Regulus Therapeutics Inc | 021-185940 | Executive Officer | 5.0 M of 5.0 M |
||
| Regulus Therapeutics Inc | 021-185938 | Executive Officer | 25.0 M of 25.0 M |
||
| Sente Inc | 021-158500 | Executive Officer | 0.1 M of 2.0 M |
||
| Sente Inc | 021-150807 | Executive Officer | 0.1 M of 0.3 M |
||
| Regulus Therapeutics Inc | 021-150538 | Executive Officer | 20.0 M of 20.0 M |
||
| Regulus Therapeutics Inc | 021-150541 | Executive Officer | 10.0 M of 10.0 M |
||
| Regulus Therapeutics Inc | 021-150536 | Executive Officer | 29.8 M of 29.8 M |
||